HIV / AIDs
Read all about the latests in HIV/Aids research and treatment protocols and also developments made into various specific components of managing this disease that is by itself also evolving.
Presented by
Source: Conference on Retroviruses and Opportunistic Infections (CROI 2019) ,Seattle.  Mar 10, 2019
A combination of two long-acting injectable anti-HIV drugs taken once monthly had a very low rate of treatment failure and a favourable safety profile, according to results from two phase III trials presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle.    Dual injections of cabotegravir, an experimental integrase inhibitor, and the n...
Source: George Mason University   Feb 15, 2019
George Mason University's Yuntao Wu is the lead scientist on a research team that has identified a measurable indicator that could prove instrumental in the fight against HIV. The research focuses on cofilin, a key protein that regulates cells to mobilize and fight against infection. In an HIV-infected patient, cofilin dysfunction is a key factor in helper T cell defects, according to the ...
Source: Simon Fraser University  Feb 03, 2019
The immune system is the body's best defense in fighting diseases like HIV and cancer. Now, an international team of researchers is harnessing the immune system to reveal new clues that may help in efforts to produce an HIV vaccine.     SFU professor Mark Brockman and co-authors from the University of KwaZulu-Natal in South Africa have identified a connection between infection cont...
Source: Howard Hughes Medical Institute  Jan 31, 2019
Researchers can now quickly and accurately count a hidden, inactive form of the human immunodeficiency virus (HIV) that lurks in patients' cells. This version of HIV embeds into cells' genomes and can persist despite otherwise successful therapies, thwarting attempts to cure the infection. Using a new genetic technique developed by Howard Hughes Medical Institute Investigator Robert Sil...
Source: Yale University  Jan 24, 2019
Much of the research on HIV has focused on preventing infection but little is understood about how the body keeps the virus in check post-infection. A new study by Yale investigators reveals the role of a protein that serves to block HIV gene expression once it has entered human cells. The research team, led by Manabu Taura, a postdoctoral fellow in the laboratory of immunobiologist  ...